home / stock / virx / virx articles

VIRX Articles, Viracta Therapeutics Inc.

Stock Information
Company Name: Viracta Therapeutics Inc.
Stock Symbol: VIRX
Market: NASDAQ
Menu
VIRX VIRX Quote VIRX Short VIRX News VIRX Articles VIRX Message Board
Get VIRX Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers repo...
Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday? | Benzinga

Monday, Viracta Therapeutics Inc (NASDAQ:VIRX) reported topline results from Stage 1 of the pivotal Phase 2 NAVAL-1 trial from both arms ...

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan | Benzinga

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on t...

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial r...
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Porch Group, Inc. (NASDAQ: PRCH) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter finan...

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference | Benzinga

SAN DIEGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on th...

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors | Benzinga

INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024 Experienced, entrepreneu...
CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Viracta Therapeutics to Present at Upcoming Investor Conferences | Benzinga

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on th...

Stocks That Hit 52-Week Lows On Thursday | Benzinga

  On Thursday, 369 companies hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market ca...
Next 10